Td Asset Management Inc Coherus Bio Sciences, Inc. Transaction History

Td Asset Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 01, 2018	SELL	$14.45 - $20.25 $235,115 - $329,487	-16,271 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$9.1 - $13.7 $5,460 - $8,220	600 Added 3.83%	16,271 $180,000
Q4 2017 Feb 02, 2018	SELL	$8.35 - $14.4 $67,635 - $116,640	-8,100 Reduced 34.08%	15,671 $138,000
Q3 2017 Nov 09, 2017	BUY	$11.1 - $14.5 $263,858 - $344,679	23,771	23,771 $317,000

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $109M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Td Asset Management Inc with notifications on news.